
L3Harris Technologies has announced plans to acquire Aerojet Rocketdyne for $4.7 billion, a transaction that, if approved, would see the nation’s sole independent solid rocket motor manufacturer bought up by a major defense prime, reported Reuters.
The deal, which was announced tonight and is subject to approval by the Federal Trade Commission, is expected to close in 2023.
Aerojet is a key supplier of propulsion systems and energetics for missiles, space systems, hypersonics and other precision weapons. It is the only US-based manufacturer of certain technologies, which has caused regulators to harshly scrutinize past attempts to purchase the company — especially after its main rival, Orbital ATK, was purchased by Northrop Grumman in 2018.
Read more: Lockheed Martin Ends $4.4B Deal To Buy Rocketdyne After Tough Merger Review
In January, the FTC filed suit to block Lockheed Martin from buying Aerojet in a $4.4 billion transaction. The regulatory body’s major concern was that, because Lockheed is one of the biggest prime contractors that makes missiles and space systems, its purchase of Aerojet would give it the chance to cut out its competition. Lockheed walked away from the deal in February.
In a statement, L3Harris and Aerojet said the newly-announced deal would bolster the defense industrial base at large.
“The acquisition will ensure the defense industrial base and our customers will have a strengthened merchant supplier to effectively address both current and emerging threats – and promote scientific discovery and innovation – through targeted investment in advanced missile technologies, hypersonics and more,” the companies said in a joint statement.
Featured News
Federal Reserve Greenlights Capital One’s $35.3 Billion Acquisition of Discover
Apr 18, 2025 by
CPI
Google to Appeal Partial Ruling in DOJ Antitrust Case
Apr 18, 2025 by
CPI
Indian Ad Agencies Warned Against WhatsApp Discussions After Antitrust Raids
Apr 17, 2025 by
CPI
US Court Ruling Against Google Spurs Fresh Antitrust Tensions in Europe
Apr 17, 2025 by
CPI
AstraZeneca Accused of Stifling Biosimilar Competition for Rare Disease Drug
Apr 17, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Airline Industry
Apr 10, 2025 by
CPI
Boosting Competition in International Aviation
Apr 10, 2025 by
Jeffrey N. Shane
Reshaping Competition Policy for the U.S. Airline Industry
Apr 10, 2025 by
Diana L. Moss
Algorithmic Collusion in the Skies: The Role of AI in Shaping Airline Competition
Apr 10, 2025 by
Qi Ge, Myongjin Kim & Nicholas Rupp
Competition in U.S. Airline Markets: Major Developments and Economic Insights
Apr 10, 2025 by
Germán Bet